Since CD200 can be expressed by both host cells and breast tumor cells in vivo, we hypothesized that the location of expression of CD200 and/or CD200R contributes importantly the mechanism(s) triggered which might lead to host tumor resistance, and help explain some of our earlier findings cited above. The gene discussed is CD200R1; the disease is neoplasm.